Importantly, despite the efficient depletion of CD19+ B cells (Fig. 7E, F), Ova-specific IgG levels were still found upregulated and the highest IgG responses correlated with HCC development independent of therapeutic regime (Fig. 7G, H). This evidence concerns the gene CD19 and hepatocellular carcinoma.